Member access

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

NOVO NORDISK A/S (NOVO.B)

235
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on NOVO NORDISK A/S
03/27DJEUROPE MARKETS : European Stocks Snap Win Streak; DAX Logs First Weekly Loss In ..
03/27DJEUROPE MARKETS : European Stocks Set To Snap String Of Weekly Wins
03/27 NNIT A/S : 14/2015 Major shareholder announcement
03/27DJEUROPE MARKETS : European Stocks Set To Break String Of Weekly Wins
03/27 BRISTOL MYERS SQUIBB : Acquires Exclusive License from Novo Nordisk
03/26 NOVO NORDISK A/S : Novo Nordisk has decided to resubmit the New Drug Application..
03/26 NOVO NORDISK A/S : A/S : has decided to resubmit the New Drug Applications of Tr..
03/26 Zosano Pharma Reports 2014 Financial Results
03/25 NOVO NORDISK A/S : Novo Nordisk completes phase 3a trials comparing faster-actin..
03/25 NOVO NORDISK A/S : A/S: completes phase 3a trials comparing faster-acting insuli..
03/24 Zosano Pharma Reports 2014 Financial Results
03/24 NOVO NORDISK A/S : Saxenda® approved in Europe for the treatment of obesity
03/24 NOVO NORDISK A/S : -Saxenda approved in Europe for the treatment of obesity
03/24DJNOVO NORDISK A/S : Gets EU Marketing Approval for Obesity Treatment
03/23 NOVO NORDISK A/S : Saxenda(r) approved in Europe for the treatment of obesity
03/23 NOVO NORDISK A/S : A/S: Saxenda® approved in Europe for the treatment of obesity
03/23 NOVO NORDISK A/S : A/S : - Share repurchase programme
03/22 NOVO NORDISK A/S : Type 1 diabetes sufferers welcome U.S. team at Tour de Taiwan
03/20 NOVO NORDISK A/S : ex-dividend day for annual dividend
03/19 NOVO NORDISK A/S : Resolutions from the Annual General Meeting of Novo Nordisk A..
03/19 Biodel Updates on Positive Preliminary Results from Study 6-101
03/18 NOVO NORDISK A/S : Data on Type 2 Diabetes Reported by Researchers at Novo Nordi..
03/18 NOVO NORDISK A/S : Type 1 Diabetes - In Search of a Cure
03/18 NOVO NORDISK A/S : BD has 6mn diabetic patients half of them unaware
03/18 NOVO NORDISK A/S : Share repurchase programme
03/17 NOVO NORDISK A/S : Share repurchase programme
03/16 NOVO NORDISK A/S : A/S : - Share repurchase programme
03/12 NOVO NORDISK A/S : Watch and Vote for Video Showing Novo Nordisk’s Approac..
03/11 NOVO NORDISK A/S : Recent Studies from Novo Nordisk Add New Data to Peptidoglyca..
03/11 NOVO NORDISK A/S : An Application for the Trademark "AWONCY" Has Been Filed by N..
03/10 NOVO NORDISK A/S : Named on the 2015 FORTUNE 100 Best Companies to Work For® Lis..
03/09 NOVO NORDISK A/S : NNE Pharmaplan delivers solid result and focuses the business
03/09 NOVO NORDISK A/S : A/S : - Share repurchase programme
03/06 NOVO NORDISK A/S : gennemfører succesfuld børsnotering af NNIT A/S
03/04 NOVO NORDISK A/S : Clear Choices - Briefing
03/04 NOVO NORDISK A/S : Study Results from Novo Nordisk in the Area of Colitis Report..
03/04 NOVO NORDISK A/S : From Denmark to Mozambique: Health on Two Wheels
03/04 NOVO NORDISK A/S : Patent Issued for Insulins with an Acyl Moiety Comprising Rep..
03/04 HYBIO PHARMACEUTICAL : Patent Application Titled "Method for Purifying Solid-Pha..
03/02 NOVO NORDISK A/S : A/S: A/S - Share repurchase programme
03/02DJNovo Increases Price Range For its IT Services' IPO
02/26 NOVO NORDISK A/S : receives Health Canada approval for Saxenda® (liraglutide) fo..
02/25DJSanofi Wins Approval For New Insulin Drug
02/25DJSanofi Wins Approval For New Insulin Drug
02/24 NOVO NORDISK A/S : sets indicative price range for the contemplated IPO of NNIT ..
02/23 NOVO NORDISK A/S : BRIEF: Diabetes group to meet
02/23 NOVO NORDISK A/S : A/S : - Share repurchase programme
02/23DJNOVO NORDISK A/S : Sets IT Unit IPO Price at DKK100-DKK120
02/23 NOVO NORDISK A/S : Notice for the Annual General Meeting of Novo Nordisk A/S; An..
02/20 NOVO NORDISK A/S : announces positive results for phase 2 trial with oral semagl..
02/20 NOVO NORDISK A/S : Trademark Application for "SEMLIFCA" Filed
02/20 NOVO NORDISK A/S : An Application for the Trademark "ZEMLOYA" Has Been Filed by ..
02/20 Notice for the Annual General Meeting of Novo Nordisk A/S
02/20 NOVO NORDISK A/S : Notice for the Annual General Meeting of Novo Nordisk A/S
02/20 NOVO NORDISK A/S : Trademark Application for "GREDUZY" Filed
02/19 NOVO NORDISK A/S : An Application for the Trademark "OZEMPIC" Has Been Filed by ..
02/19 NOVO NORDISK A/S : International GPCR Consortium Announces Addition of New Membe..
02/19 NOVO NORDISK A/S : Trademark Application for "BESQW" Filed by Novo Nordisk A/S
02/19 NOVO NORDISK A/S : Trademark Application for "OSEMPIC" Filed by Novo Nordisk A/S
02/19 NOVO NORDISK A/S : "GLP-1 Agonists" in Patent Application Approval Process
02/19 NOVO NORDISK A/S : An Application for the Trademark "CIVOVIC" Has Been Filed by ..
02/19 NOVO NORDISK A/S : Trademark Application for "VUDECRI" Filed by Novo Nordisk A/S
02/16 NOVO NORDISK A/S : Changes to the Supervisory Board of Carlsberg A/S
02/16 NOVO NORDISK A/S : A/S : - Share repurchase programme
02/12 NOVO NORDISK A/S : Sweden, Denmark to collaborate on diabetes research
02/11 NOVO NORDISK A/S : Karolinska Institutet partner for diabetes research program
02/11 NOVO NORDISK A/S : and Karolinska Institutet join forces in the field of diabete..
02/11 NOVO NORDISK A/S : and Karolinska Institutet join forces in the field of diabete..
02/10 NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
02/10 NOVO NORDISK A/S : Share repurchase programme
02/09 NOVO NORDISK A/S : A/S: Trading in shares by board members, executives and assoc..
02/09 NOVO NORDISK A/S : A/S : A/S - Share repurchase programme
02/09DJNOVO NORDISK A/S : Seeks Copenhagen IPO of IT Services Unit NNIT
02/06 NOVO NORDISK A/S : A/S: Trading in shares by board members, executives and assoc..
02/05 NOVO NORDISK A/S : files annual report with the SEC
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF